Indian rheumatologists view standalone centres of care to ensure easy access ... pharmabiz.com A slew of newer disease-modifying biologics like etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade), rituximab (Rituxan) and abatacept (Orencia) are available. According to Dr Manish Dugar, rheumatologist, Apollo Hospitals, Hyderabad, ... |
